BRISTOL-MYERS SQUIBB COMPANY Inventory, Work in Process, Gross
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Inventory, Work in Process, Gross of $994.00 million as of 2018-09-30, per its 10-Q filed 2018-10-25.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2018-10-25
- 2018-09-30: Inventory, Work in Process, Gross $994.00M.
- 2018-06-30: Inventory, Work in Process, Gross $982.00M.
- 2018-03-31: Inventory, Work in Process, Gross $932.00M.
- 2017-12-31: Inventory, Work in Process, Gross $931.00M.
| Period end | Inventory, Work in Process, Gross | Inventory, Work in Process, Gross as first filed |
|---|---|---|
| 2018-09-30 | $994.00M 10-Q · filed 2018-10-25 | |
| 2018-06-30 | $982.00M 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $932.00M 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $931.00M 10-Q · filed 2018-10-25 | |
| 2017-09-30 | $956.00M 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $927.00M 10-Q · filed 2017-07-27 | |
| 2017-03-31 | $1.04B 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $988.00M 10-K · filed 2018-02-13 | |
| 2016-09-30 | $952.00M 10-Q · filed 2016-10-27 | |
| 2016-06-30 | $977.00M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $919.00M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $868.00M 10-K · filed 2017-02-21 | $646.00M 10-K · filed 2016-02-12 |
| 2015-09-30 | $561.00M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $642.00M 10-Q · filed 2015-07-23 | |
| 2015-03-31 | $689.00M 10-Q · filed 2015-04-28 | |
| 2014-12-31 | $856.00M 10-K · filed 2016-02-12 | |
| 2014-09-30 | $787.00M 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $800.00M 10-Q · filed 2014-07-24 | |
| 2014-03-31 | $886.00M 10-Q · filed 2014-04-29 | |
| 2013-12-31 | $757.00M 10-K · filed 2015-02-13 | |
| 2013-09-30 | $810.00M 10-Q · filed 2013-10-23 | |
| 2013-06-30 | $858.00M 10-Q · filed 2013-07-25 | |
| 2013-03-31 | $884.00M 10-Q · filed 2013-04-25 | |
| 2012-12-31 | $814.00M 10-K · filed 2014-02-14 | |
| 2012-09-30 | $868.00M 10-Q · filed 2012-10-24 | |
| 2012-06-30 | $755.00M 10-Q · filed 2012-07-25 | |
| 2012-03-31 | $721.00M 10-Q · filed 2012-04-26 | |
| 2011-12-31 | $646.00M 10-K · filed 2013-02-15 | |
| 2011-09-30 | $709.00M 10-Q · filed 2011-10-27 | |
| 2011-06-30 | $698.00M 10-Q · filed 2011-07-28 | |
| 2011-03-31 | $690.00M 10-Q · filed 2011-04-28 | |
| 2010-12-31 | $608.00M 10-K · filed 2012-02-17 | |
| 2010-09-30 | $635.00M 10-Q · filed 2010-10-26 | |
| 2010-06-30 | $446.00M 10-Q · filed 2010-07-22 | |
| 2009-12-31 | $630.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |